Canada Pension Plan Investment Board
DNA icon

Canada Pension Plan Investment Board’s Ginkgo Bioworks DNA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+22,500
New +$188K ﹤0.01% 1572
2023
Q1 		– Sell
-1,273
Closed -$86K – 1106
2022
Q4 		$86K Sell
1,273
-7,120
-85% -$655K ﹤0.01% 1038
2022
Q3 		$1.05M Buy
8,393
+6,333
+307% +$755K ﹤0.01% 865
2022
Q2 		$196K Buy
+2,060
New +$251K ﹤0.01% 1081

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Canada Pension Plan Investment Board's DNA Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 22,500 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1572 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in DNA as recently as Q4 2022.

Canada Pension Plan Investment Board first reported a position in DNA in Q2 2022 and has held it in 4 quarters since. The position peaked at $1.05M in Q3 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Canada Pension Plan Investment Board held 22,500 shares of Ginkgo Bioworks worth $223K as of Q2 2026.
  • Ginkgo Bioworks was a new Canada Pension Plan Investment Board position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1572 holding.
  • Canada Pension Plan Investment Board first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Ginkgo Bioworks position peaked at $1.05M in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.